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a-Hemolysin (HlyA) is an exotoxin secreted by some patho­
genic strains of Escherichia coli that causes lysis of several mam­
malian cells, including erythrocytes of different species. HlyA is 
synthesized as a protoxin, pro-HlyA, which is activated by acy­
lation at two internal lysines Lys-563 and Lys-689. It has been 
proposed that pore formation is the mechanism of cytolytic 
activity for this toxin, as shown in experiments with whole cells, 
planar lipid membranes, and liposomes, but these experiments 
have yielded conflicting results about the structure of the pore. 
In this study, HlyA cysteine replacement mutant proteins of 
amino acids have been labeled with Alexa-488 and Alexa-546. 
Fluorescence resonance energy transfer measurements, 
employing labeled toxin bound to sheep ghost erythrocytes, 
have demonstrated that HlyA oligomerizes on erythrocyte 
membranes. As the cytotoxic activity is absolutely dependent on 
acylation, we have studied the role of acylation in the oligomer­
ization, demonstrating that fatty acids are essential in this proc­
ess. On the other hand, fluorescence resonance energy transfer 
and the hemolytic activity decrease when the erythrocyte ghosts 
are cholesterol-depleted, hence indicating the role of membrane 
microdomains in the clustering of HlyA. Simultaneously, HlyA 
was found in detergent-resistant membranes. Pro-HlyA has 
also been found in detergent-resistant membranes, thus dem­
onstrating that the importance of acyl chains in toxin oli­
gomerization is the promotion of protein-protein interac­
tion. These results change the concept of the main role 
assigned to acyl chain in the targeting of proteins to mem­
brane microdomains.
Escherichia coli a-hemolysin, HlyA,4 is an exotoxin that elic­
its a number of responses from mammalian target cells and also 
alters the membrane permeability of host cells, causing lysis 
and death (1, 2). Synthesis, maturation, and secretion off. coli 
HlyA are determined by the hlyCABD operon (3). The gene A 
product is a 110-kDa polypeptide corresponding to protoxin 
(Pro-HlyA), which is matured in bacterial cytosol to the active 
form (HlyA) by HlyC-directed acylation. This post-transla- 
tional modification involves a covalent amide linkage of fatty 
acids at two internal lysine residues (Lys-563 and Lys-689) for 
activation (4). HlyA activated in vivo consists of a heterogene­
ous family of up to nine different covalent structures (two acy­
lation sites and three possible modifying groups in each site, 
C14:0 (68%), C15:0 (26%) and C17:0 (6%) (5)). Although these 
fatty acids are not required for the binding of the toxin to mem­
branes, they are essential for the hemolytic process, inducing a 
molten globule conformation and promoting the irreversibility 
of the binding (6, 7).
It has been proposed that pore formation is the mechanism 
of cytolytic activity for this toxin, as shown in experiments with 
whole cells, planar lipid membranes, and liposomes. However, 
these experiments have yielded conflicting results. Although a 
group of researchers is in favor of a monomer as the active 
species of the toxin in membranes, other groups postulate that 
an oligomerization process is involved. Based on experiments 
with lipid bilayers, Menestrina etal. (8) have suggested that one 
single HlyA molecule is responsible for the formation of the 
channel. HlyA has also been recovered from deoxycholate-sol- 
ubilized erythrocyte membranes as a monomer, indicating 
either that oligomerization is not required for pore formation 
or that oligomers are dissociated in the detergent (1).
On the other hand, Benz et al. (9) have found that small 
variations of toxin concentration have had a considerable effect 
on the specific membrane conductance. An increase in HlyA 
concentration, by a factor of 5, results in about 40-100-fold 
higher membrane conductance. This means that several HlyA 
molecules could be involved in channel formation (9). Besides, 
they have found that the active channel-forming oligomer and 
inactive monomer are in an association-dissociation equilib­
rium (10). In addition, the complementation of inactive deleted 
mutant proteins of HlyA with the corresponding wild type 
toxin produces hemolytic activity, suggesting that two or more 
toxin molecules aggregate before pore formation (11). All of the 
evidence suggests the formation of an oligomer.
Experiments employing erythrocytes and model membranes 
have shown that the lesion created by HlyA is perhaps a more 
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complicated event than the creation of a simple, static protein- 
lined pore. We have recently found that addition of nanomolar 
concentrations of toxin to planar lipid membranes have 
resulted in a decrease in membrane lifetime up to 3 orders of 
magnitude in a voltage-dependent manner, a typical behavior 
of proteolipidic pores (12). Moayeri and Welch (13) have pre­
viously demonstrated that osmotic protection of erythrocytes 
by sugars of different sizes is a function of toxin concentration 
and assay time. It appears that HlyA induces heterogeneous 
erythrocyte lesions that increase in size over time and that the 
rate of the putative growth in the size of HlyA-mediated lesions 
is temperature-dependent (13).
On the other hand, it has been recognized that a variety of 
pathogens and toxins interacts with microdomains in the 
plasma membrane. These microdomains are enriched in cho­
lesterol and sphingolipids and probably exist in a liquid-or­
dered phase, in which lipid acyl chains are extended and 
ordered (14). Many proteins are targeted to these membrane 
microdomains by their favorable association with ordered lip­
ids. Interestingly, these proteins are linked to saturated acyl 
chains, which partition well into these domains (15).
In this context, and in view of the fact that acyl chains 
covalently bound to proteins are determinant of specific pro­
tein-protein interactions, this research presents a study of HlyA 
oligomerization on sheep erythrocytes, as well as the implica­
tion of fatty acids and cholesterol-enriched microdomains in 
this process.
EXPERIMENTAL PROCEDURES
Proteins and Mutant Proteins
HlyA is a protein of 1023 amino acids devoid of cysteine. 
HlyA and Pro-HlyA were purified from culture filtrates of E. 
coli strains WAM 1824 (16) and WAM 783, respectively (17). 
The HlyA cysteine mutant protein K344C (HlyA K344C) was 
purified from the E. coli strain WAM 2205 (18), which was 
kindly provided by Dr. R. A. Welch, University of Wisconsin, 
Madison. Pro-HlyA cysteine mutant protein (Pro-HlyA 
K344C) was obtained by site-directed mutagenesis of plasmid 
(pSE4()()()A/>aw/H7) extracted from WAM 783, using the 
QuickChange method (Stratagene, Cedar Creek, TX). The 
sequence for the coding strands of mismatch primer was as 
follows: 5'-CCATCGTATCCAAGGCATTTGAATCGTTG- 
TGAATACTCC-3'; The mismatch codon is underlined. The 
mutation has been confirmed by DNA sequencing at Macrogen 
(Seoul, Korea). The mutated plasmid was transformed into 
E. coli BL-21 for further purification of Pro-HlyA K344C.
Protein Purification
Cultures of the corresponding E. coli strain were grown to 
late log phase in Luria-Bertani medium to an absorbance at 600 
nm (A600) of 0.8-1.0. Cells were pelleted, and the supernatant 
was concentrated and partially purified by precipitation with 
20% cold ethanol. The precipitate containing the protein was 
collected by centrifugation (1 h, 14,500 X g in a Sorvall centri­
fuge, rotor SSA 34) and then resuspended in 20 mM Tris, pH 7.4, 
and 150 mM NaCl (TC buffer). SDS-PAGE analysis of this prep­
aration showed a main band at 110 kDa corresponding to more 
than 90% of the total protein. Proteins of lower molecular mass 
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were removed by dialysis (membrane cutoff, 30 kDa). The pro­
tein was stored at —70 °C in 20 mM Tris, pH 7.4,150 mM NaCl, 
and 6 m guanidine hydrochloride (TCGn). Proteins were first 
dialyzed in TC (1:100 v/v) before each experiment at 4 °C 
for 4 h.
The purification of Pro-HlyA and Pro-HlyA K344C by the 
same process employed for HlyA gave low yield, so it was puri­
fied from inclusion bodies as described by Sanchez Magraner 
etal. (19).
Measurements of Intrinsic Fluorescence
Protein intrinsic fluorescence spectra were recorded on a 
SLM 4800 Aminco spectrofluorometer. The excitation wave­
length was 295 nm to minimize tyrosine emission, and the 
emission spectra were recorded in the 310-370 nm wavelength 
range. Slit width was 4 nm for both excitation and emission.
Labeling of Mutant Proteins with Fluorescence Probes
HlyA and Pro-HlyA cysteine mutant proteins in degassed 
TCGn at pH 7.4 were incubated with sulfhydryl-specific probes 
at room temperature for 1 h in the presence of 0.4 mM tris(2- 
carboxyethyl)phosphine hydrochloride. The probes (dissolved 
in the same buffer) were added in small volumes while stirring 
in the dark. Alexa-488 was added to a final molar ratio of 30:1 
probe to protein. A molar excess of 5:1 probe to protein and 
0.1% sodium cholate were used for the specific labeling with 
Alexa-546. Labeled proteins were separated from unbound 
probe by elution through PD-10 columns (GE Healthcare) and 
dialysis overnight into TC buffer. HlyA was reacted alongside 
the mutant proteins to detect nonspecific labeling. The effi­
ciency of labeling was determined from the molar extinction 
coefficients for Alexa-488, e492 = 67,100 cm m ', and for 
Alexa-546, e554 = 90,300 cm m 1 (specifications from 
Molecular Probes) and e280 = 73,960 cm 1 m 1 for HlyA. All 
mutant proteins were specifically labeled (molar ratio 0.9-1.1 
probe to protein). The nonspecific labeling detected with the 
wild type toxin HlyA was <10%. The hemolytic activity of the 
HlyA K344C mutant protein was not detectably decreased by 
labeling.
Hemolytic Assays
The hemolysis was determined by measuring the decrease in 
turbidity (scattered light at 595 nm) of a standardized sheep 
erythrocyte suspension. Proteins were serially diluted in TC 
buffer containing 10 mM CaCl2 on a 96-well microtiter plate. 
One hundred /xl of the diluted suspensions were mixed with 
100 p.1 of standardized sheep erythrocytes.
The standardization of the sheep erythrocytes was done just 
before the assay. The erythrocytes were washed in 0.9% NaCl 
and then diluted to 12.5 pl in 1 ml of distilled water to give a 
reading of 0.6 absorbance unit at 412 nm (20).
The plate was then incubated at 37 °C for 30 min, and the 
absorbance at 595 nm was measured at a Multimode Detector 
DTX 880 Beckman Coulter.
The hemolysis percentage was calculated as shown in 
Equation 1,
% hemolysis = (ODc-ODx) • 100/(ODc-ODTx) (Eq. 1) 
VOLUME 284-NUMBER 37-SEPTEMBER 11,2009
Downloaded f rom
 http://www.jbc.org by guest on August 23. 2019
Oligomerization of HlyA ofE. coli
where ODc is the optical density of control erythrocytes; ODx is 
the optical density of erythrocytes treated with different con­
centrations of toxin, and ODTx is the optical density of eryth­
rocytes after Triton X-100 addition.
The hemolytic activity is defined as the dilution of HlyA 
preparation producing 50% lysis of the erythrocyte suspension. 
Specific activity is calculated as the hemolytic activity (in hemo­
lytic units/ml) of the respective protein divided by its concen­
tration (mg/ml).
Cholesterol Depletion
Cholesterol extraction from sheep erythrocytes was per­
formed by two methods, one using small unilamellar vesicles 
made of egg phosphatidylcholine (SUV-PC) (21) and the other 
employing a 3 mM methyl-/3-cyclodextrin (CD) solution (22).
Sheep erythrocytes (10% hematocrit) were incubated with 1 
jumol of SUV-PC at 37 °C. After 3 h, the cells were sedimented 
and washed five times with TC buffer.
For the cholesterol extraction using CD (Fluka), 1 ml of sheep 
erythrocytes was incubated with 10 ml of 3 mM CD in TC buffer 
at 37 °C for 30 min and washed three times with TC buffer. Half 
of the cells were used for experiments, and the other half was 
used for cholesterol quantification (Colestat, Weiner).
Hemolysis Kinetics
Hemolysis kinetics was determined by measuring the 
decrease in turbidity of a standardized sheep erythrocyte sus­
pension (control and cholesterol-depleted) exposed to HlyA as 
a function of time at 37 °C. A series of hemolytic reactions were 
set up. The highest concentration of HlyA studied (0.2 /j,m) 
corresponded to the minimal amount of toxin that would pro­
duce 100% of hemolysis in 96-well plate dilution assays. The 
absorbance at 595 nm was measured at a Multimode Detector 
DTX 880 from Beckman Coulter. Initial rate of hemolysis was 
obtained from the linear portion of the kinetic curve (absorb­
ance at 595 nm versus time).
Ghost Erythrocyte Preparation
1.5 milliliters of packed sheep erythrocytes (control and cho­
lesterol-depleted) were washed with TC buffer and osmotically 
lysed in 10 mM Tris-HCl, pH 7.4 buffer, at 4 °C for 30 min. The 
membranes were pelleted by centrifugation (10 min at 14,500 X 
g) and washed until the supernatant remained clear. The mem­
branes were finally resuspended in 3 ml of TC buffer. The con­
centration of these samples was 0.51 ± 0.06 mg of phospholip- 
id/ml (m = 3).
Binding of Labeled Proteins to Ghost Erythrocytes
Twenty micrograms of protein was incubated with 75 pi of 
sheep ghost erythrocytes at 37 °C for 60 min in a TC buffer 
containing 10 mM CaCl2. The resulting final reaction volume 
was 1 ml. Membranes were pelleted by centrifugation (10 min, 
14,500 x g, 4 °C) and washed three times with TC buffer to 
separate unbound protein. Binding percentage of protein to 
membranes was calculated as shown in Equation 2,
% binding = ((FT — Fsup)/FT) • 100 (Eq.2) 
'Vsbmb\
where FT is the maximum fluorescence of the corresponding 
labeled protein before its interaction with membranes, and sup 
is the fluorescence measured in the supernatant after the three 
washes. A blank of buffer and membranes was subtracted from 
all fluorescence measurements.
For proteins labeled with Alexa-488, the excitation wave­
length was 480 nm, and emission fluorescence was measured at 
520 nm, and proteins labeled with Alexa-546 were excited at 
530 nm, and emission was measured at 570 nm.
Fluorescence Resonance Energy Transfer (FRET) 
Measurements
Fluorescence resonance energy transfer is a distance­
dependent interaction between the electronic excited states of 
two fluorescent molecules, in which excitation energy is trans­
ferred from a donor molecule (D) to an acceptor molecule (A), 
without emission of a photon. The efficiency of energy transfer 
(£) is related to Ro, the Forster radius, and to R, the distance 
between donor and acceptor, as shown by the Equation 3,
E = R60/(R60 + R6) (Eq. 3)
Ro represents the distance where the transfer is 50% efficient 
(23).
When donor and acceptor probes in FRET experiments are 
chemically different, FRET can be detected by the following: (a) 
the increase in the fluorescence intensity of the acceptor; (b) the 
decrease in the fluorescence intensity of the donor; or (c) the 
decrease in the fluorescence lifetime of the donor. For our 
experiments, Alexa-488 (D) and Alexa-546 (A) were chosen as 
donor and acceptor, respectively, and method a was selected for 
the determination of FRET efficiencies. For each HlyA mutant 
protein tested, three samples were measured differing in the 
contents of the labeled variants (D and A) and in the corre­
sponding unlabeled mutant protein: (a) D/unlabeled mutant 
protein, (b) D/A, and (c) unlabeled mutant protein/A. The 
molar ratio between donor and acceptor was 1:1.
Determination of the Enhancement of the Acceptor 
Fluorescence Emission
FRET was calculated from spectral data as described by 
Gohlke et al. (24). This approach allows for the calculation of£ 
from three fluorescence spectra. The fluorescence emission 
spectrum of ghost erythrocytes containing D/A, Fl)/A (480, Xem) 
(excited at 480 nm), is fitted to the weighted sum of two spectral 
components as follows: (a) a standard emission spectrum of 
ghost erythrocytes labeled only with donor, £D(480, Xem), and 
(b) a spectrum of ghost erythrocytes containing D/A, Fl)/A (530, 
Xem) (excited at 530 nm where only the acceptor absorbs), as 
shown in Equation 4,
FD/A(480,Àem) = a • FD(480,Àem) + b • FD/A(530,Àem)
(Eq. 4)
The coefficients a and b are the fitted fractional contribu­
tions of the two spectral components; b is the acceptor fluores­
cence signal due to FRET from the donor, normalized by 
£d/a(530 nm, Àem). E was obtained as shown in Equation 5, 
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using the b value obtained from the fitting of the spectra using 
Sigmaplot 8.0 (Jandel Scientific, San Rafael, CA).
7(480) 7(480)
b E ' eA(530) ' 7(530) (Eq 5)
eD and 7 are the molar absorption coefficients of D and A at 
the given wavelengths, respectively; eD(480 nm)/7(53() nm) 
and 7(480 nm)/7(530 nm) were determined from the absorp­
tion spectra of D and A in singly labeled preparations (D/HlyA 
and HlyA/A). The absorption spectrum of membranes with 
unlabeled toxin was subtracted in all the samples.
For FRET measurements, mutant proteins labeled with both 
fluorophores (ranging from 3 to 50 /xg of total protein) were 
added to 75 pl of ghost erythrocyte suspension. The condition 
for the binding of the proteins to ghost membranes was the one 
previously described. Steady-state fluorescence spectra were 
recorded at room temperature on an SLM 4800 Aminco spec­
trofluorometer. Alexa-488 was excited at 480 nm, and emission 
was recorded between 470 and 600 nm. Direct excitation of 
Alexa-546 was achieved at 530 nm, and the emission was 
recorded between 540 and 600 nm.
FRET Kinetics
For kinetics studies, ghost erythrocytes were mixed with 
either donor plus acceptor or acceptor plus unlabeled HlyA 
K344C using a stopped flow (RX 2000, Applied Photophysics 
Ltd.) adapted to the SLM 4800 Aminco spectrofluorometer. 
Assays were performed as follows: 5 /xg of total toxin per 100 /xg 
of phospholipids (erythrocytes membranes). The excitation 
monochromator was set at 480 nm, and the emission mono­
chromator was set at 570 nm with 8 nm slit widths. Alexa-546 
emission was measured at a rate of 25 samples/s for 240 s at 
37 °C. The curves represent the average of three independent 
experiments obtained from five replicates each.
Isolation of Detergent-resistant Membranes (DRMs) by 
Sucrose Gradient Centrifugation
We adapted the procedure from that of Quinn and co-work­
ers (25). One volume of protein-bound ghost erythrocytes was 
resuspended in 4 volumes of TNE buffer (10 mM Tris, 200 mM 
NaCl, 1 uimEDTA, pH 7.4) containing 1% (v/v) Triton X-100 at 
4 °C and dispersed by 10 passages through a 21-gauge needle. 
The mixture was incubated on ice for 20-30 min. The lysate 
was diluted with an equal volume of 80% (v/v) sucrose solution 
in TNE buffer. One ml of this suspension was overlayered by 2.3 
ml of 35% sucrose solution in TNE buffer, followed by 1 ml of a 
5% sucrose solution in TNE buffer. The samples were centri­
fuged at 190,000 X gin a Beckman SW60 Ti rotor at 4°C for 
18 h. Twelve 0.33-ml fractions were collected from the top of 
each tube. Pelleted material recovered from the bottom of the 
tube was named “P” fraction, and the material layered at the 
5-35% sucrose interface was designated as DRMs (fractions 
3-5). All fractions were stored frozen at —20 °C prior to further 
analysis.
Analysis of Sucrose Density Gradient Fractions
Immunoblotting Analysis—1Fifteen microliters from each of 
the 13 sucrose fractions were separated by 10% SDS-polyacryl- 
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amide gels and transferred to nitrocellulose membrane by the 
Towbin et al. method (26). Blots were blocked with 3% skim 
milk in PBST buffer (140 mM NaCl, 2.7 mM KC1, 1.5 mM 
KH2PO4, 8.1 mM Na2HPO4, and 0.05% Tween, pH 7.4) at room 
temperature for 2 h. They were then incubated with a solution 
containing a polyclonal rabbit anti-hemolysin antibody (1:500) 
or anti-Flotillin-1 antibody (Santa Cruz Biotechnology, Inc.) 
(1:1000) in 3% skim milk/PBST at 4 °C overnight, washed 
with PBST buffer, and finally reacted with peroxidase-con- 
jugated anti-rabbit IgG antibody (Sigma) (1:1000) in PBST 
buffer with 3% skim milk at room temperature for 2 h. After 
incubation and washing as stated above, blots were devel­
oped by chemiluminescence.
Lipid Analysis—Total lipids of sucrose density gradient 
fractions were extracted by procedure of Floch et al. (27). 
Lipids were recovered from the original chloroform extract 
and subjected to analysis by TLC on high performance TLC 
plates (Whatman), developed with a two solvent system 
consisting first of chloro form/methanol/acetic acid/water (25: 
18.75:1.75:1 by volume) and then with hexane/diethyl ether/ 
acetic acid (40:10:1 by volume). Lipid spots were detected by 5% 
sulfuric acid in ethanol.
RESULTS
Mutant Protein Characterization—HlyA does not contain 
Cys residues in its sequences; therefore, Lys-344 was replaced 
by Cys (HlyA K344C). The same point mutation was intro­
duced in the unacylated protein (Pro-HlyA K344C). Prior to the 
FRET experiments, the hemolytic activity of the mutant pro­
teins has been measured and compared with the wild type toxin 
(HlyA). Fig. 1A shows that mutation located in the insertion 
region of the toxin into membranes (28) does not affect the 
hemolytic activity of the toxin. As expected, Pro-HlyA K344C is 
hemolytically inactive as Pro-HlyA, because the fatty acids 
covalently bound are lacking in both proteins.
As HlyA contains hydrophobic domains in its sequence, it 
presents a great tendency to aggregate. The aggregation per­
centage of each protein in solution was measured. Briefly, 20 
/xg/ml of protein in TC buffer was centrifuged at 110,000 X g in 
a Beckman 70.1 rotor at 4 °C for 2 h. The amount of proteins in 
the pellet (aggregates) and supernatants was quantified by the 
Bradford procedure. The aggregation percentage obtained was 
21.6 ± 1.6 and 15.9 ± 0.48% for HlyA K344C and Pro-HlyA 
K344C, respectively. If we compare these values with the aggre­
gation percentage ofthe wild type protein (27.2 ± 5%), the HlyA 
mutant protein does not present any difference with HlyA. 
Instead, Pro-HlyA has less of a tendency to aggregate, probably 
because of its compact structure (6).
HlyA contains four tryptophan residues that can serve as 
intrinsic fluoropho res. They are located at positions 431, 479, 
578, and 913. Fig. IB shows that maximum emission does not 
change because of the presence of mutation, indicating that the 
Cys introduced does not induce important conformational 
changes in either HlyA or Pro-HlyA. The blue shift of Pro-HlyA 
indicates that the Trp residues are located in a more hydropho­
bic environment than in the acylated protein as published 
before (7).
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FIGURE 1. Characterization of HlyA and Pro-HlyA cysteine mutants. A, spe­
cific hemolytic activity of the different cysteine mutant proteins (n = 3) com­
pared with the wild type toxin. HU, hemolytic units. 8, emission spectra of Trp 
of wild type (WT) HlyA (solid black line), HlyA K344C (light gray dashed line), 
Pro-HlyA K344C (dark gray dashed line), and Pro-HlyA (black dotted line). The 
amount of toxin measured was of lOg/ml, Ap./( was 295 nm.
FRET Experiments to Determine FIlyA Oligomerization— 
Resonance energy transfer is a photochemical process whereby 
one fluorescent molecule or fluorophore, the “donor,” excited 
by an initial photon of light spontaneously transfers its energy 
to another molecule, the “acceptor,” by a nonradioactive 
dipole-dipole interaction (29, 30).
The distance over which energy can be transferred 
depends on the spectral characteristics of the fluorophores, 
but it is generally in the 10-100-A range. Hence, FRET can 
be used for measuring structure (31), conformational 
changes (32), and interactions between molecules (33). This 
has been the aim of our experiment, where labeled mutant 
proteins of HlyA have been used to study the oligomeriza­
tion of the toxin on erythrocytes membranes. To carry out 
this study, two populations of HlyA K344C mutant proteins, 
one labeled with donor (Alexa-488) and the other with 
acceptor fluorophores (Alexa-546), have been bound to 
sheep ghost erythrocytes.
The hemolytic activity of the labeled proteins has been the 
same as that of the unlabeled ones, indicating that the presence 
of fluorophores does not change the active conformation of the 
toxin. On the other hand, the binding percentage of the mutant
5.0e+8
wavelength (nm)
Do 
oade 
nom 
ttp. 
bco 
b 
guesi on Augusi ?
; 20I9
FIGURE 2. FRET, a method used to study oligomerization. A, fluorescence 
spectra of a mixture of HlyA K344C D and HlyA K344C A in theabsence (darkcircle) 
and presence (light gray circle) of ghost erythrocytes. The excitation wavelength 
was set at 480 nm and emission was scanned from 500 to 620 nm. The initial 
amounts of protein and ghost erythrocytes phospholipids used were 20 and 37.5 
/j.g, respectively. The molar ratio was 1:1 donor to acceptor. Blanks of buffer, 
membranes, and acceptor fluorescence excited at 480 nm were subtracted from 
all spectra. 8, FRET measurement calculated as the enhancement of acceptor 
fluorescence at different lipid/protein molar ratio. Lipids concentration was 0.05 
mM. This graph represents an example of four experiments. C, example of the 
three spectra measured at 1.2 x 109 lipid/protein ratio. Fluorescence emission 
spectrum of ghost erythrocytes containing D/A, F°/A(480, Àem) (excited at 480 
nm) (•), emission spectrum of HlyA labeled only with donor, bound to ghost 
erythrocytes F°(480, Aprn) (invertedgray triangle), spectrum of ghost erythrocytes 
containing D/A, FD/A(530, APrn) (excited at 530 nm where only the acceptor 
absorbs) (■), and emission spectrum of HlyA labeled only with acceptor, bound 
to ghost erythrocytes FA(480, Aem) (light gray circle).
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FIGURE 3. Oligomerization of HlyA in ghost erythrocytes. FRET calculated for HlyA K344C and Pro-HlyA K344C was bound to ghost erythrocytes. The 
lipid/protein ratio was 109. FRET was calculated as mentioned before under "Experimental Procedures" (n = 4). Inset, example of spectra measured for Pro-HlyA 
K344C. Fluorescence emission spectrum of ghost erythrocytes containing D/A, FD/A(480, Xem) (excited at 480 nm) (•), emission spectrum of ghost erythrocytes 
labeled only with donor, F°(480, Xem) (light gray circle), and spectrum of ghost erythrocytes containing D/A, F°/A(530, Xem) (excited at 530 nm where only the 
acceptor absorbs) (inverted gray triangle).
proteins labeled with both fluorophores to ghost erythrocytes 
has been calculated as described under “Experimental Proce­
dures.” The mean binding percentage of three independent 
experiments has been 23.47 ± 3.61 and 15.36 ± 5.63% for HlyA 
K344C Alexa-546 (HlyA A) and HlyA K344C Alexa-488 (HlyA 
D), respectively. The difference is not significant, demonstrat­
ing that fluorophores do not change the binding properties of 
the toxin. These values give us the certainty that the ratio of D: A 
added in the following experiments is maintained when the 
toxin is bound to membranes.
The fluorescence emission spectrum of a mixture containing 
HlyA D and HlyA A in solution at a molar ratio of 1:1 was then 
recorded. Fig. 2A shows that the emission fluorescence of that 
mixture corresponds to the fluorescence emission of donor; 
otherwise, when ghost erythrocytes are added, an enhancement 
of acceptor fluorescence is observed. This result demonstrates 
that the small aggregation of the toxin in solution (21.6 ± 1.6%, 
as described before) is not detected by FRET, but when ghost 
erythrocytes are added some molecules of the protein get in 
close proximity.
FRET, calculated as the enhancement of acceptor fluores­
cence, has been measured as a function of lipid/protein ratio. 
Fig. 2B shows that FRET decreases with the enhancement of 
the lipid/protein ratio until it reaches a constant value, indi­
cating that FRET can be measured, even when the amount of 
protein is very small. This means that at least two molecules 
of HlyA are close enough to transfer fluorescence energy, 
forming an oligomer when the toxin is bound to a mem­
brane. An example of the spectra employed to calculate 
FRET is shown in Fig. 2C.
Implication of Fatty Acids Covalently Bound to HlyA in the 
Oligomerization Processes—Taking into account that the 
two fatty acids covalently bound to the toxin induce a molten 
globule conformation, exposing intrinsic disordered regions 
that may promote protein-protein interactions, we have 
designed the mutant protein Pro-HlyA K344C. This protein 
is the inactive form of HlyA (without both acyl chains) with 
mutation introduced in the insertion region. Fig. 3 shows 
that its analogous mutant protein in the active protein (HlyA 
K344C) presents FRET, so construction of this mutant pro­
tein ensures that the distance and orientation of the fluoro- 
phores are adequate for FRET occurrence. However, this 
Pro-HlyA mutant protein does not present FRET. It is 
important to mention that the binding percentage of Pro- 
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HlyA and HlyA to ghost erythrocytes is 24.8 ± 6.09 and 
23.47 ± 3.61%, respectively. This is consistent with what has 
been published by Soloaga et al. (45). This result supports 
that the absence of FRET in the Pro-HlyA mutant protein 
is because of the fact that oligomerization does not occur, 
thus indicating the implication of fatty acids in this process.
Role of Cholesterol-enriched Microdomains in the Action 
Mechanism ofHlyA—Krioynng that HlyA has to be acylated to 
be active and that some acylated proteins interact with mem­
brane microdomains, we have studied their role in the hemo­
lytic process. For this purpose, and taking into account that 
these microdomains are enriched in cholesterol and sphingo­
lipids, the hemolytic activity of the toxin on sheep erythrocytes 
has been compared with the activity on erythrocytes cholester- 
ol-depleted by SUV-PC. This method has been used because 
cholesterol efflux with CD led to spontaneous hemolysis. The 
cholesterol content of the membranes was decreased by 
approximately 30%. When hemolysis kinetics was measured in 
both control and cholesterol-depleted erythrocytes, the latter 
were less sensitive to toxin. As shown in Fig. 4A, the initial 
hemolysis rate is lower for cholesterol-depleted erythrocytes 
than for the one obtained with control erythrocytes for all toxin 
amounts tested. This result indicates that cholesterol-enriched 
microdomains facilitate the hemolytic process. Moreover, Fig. 
4/3 shows that t50 values (time to reach 50% of hemolysis) are 
longer for cholesterol-depleted erythrocytes than for control 
ones.
To determine whether the decrease of the hemolytic rate 
observed in the cholesterol-depleted erythrocytes is caused by 
the impairment of toxin oligomerization, we repeated the FRET 
experiments using sheep ghost erythrocytes cholesterol-de­
pleted by CD. In this case, the cholesterol content of the mem­
brane was also decreased by approximately 30%. The binding 
percentage of HlyA to ghost cholesterol-depleted erythrocytes 
is 17.44 ± 1.46%. By comparing this value with the binding 
percentage of the protein to control ghost erythrocytes 
(23.47 ± 3.61%), it is possible to conclude that the changes 
produced in the membrane by the extraction of cholesterol do 
not significantly modify the binding percentage of the toxin to 
membranes.
FRETs of HlyA K344C bound to control and cholesterol- 
depleted ghosts are shown in Fig. 5. As shown in Fig. 5, CD 
treatment led to a decrease of 75% of FRET compared with 
control. This result suggests that cholesterol-enriched 
microdomains play an important role in the oligomerization 
process.
FRET kinetics has been performed to obtain a more 
detailed study of the effect of cholesterol-enriched microdo­
mains in the oligomerization process. Fig. 6 shows the 
enhancement of acceptor fluorescence for 4 min after mix­
ing labeled HlyA K344C (acceptor and donor fluorophores) 
with control and cholesterol-depleted ghost erythrocytes. 
The curves in Fig. 6 show biphasic behavior of the enhance­
ment of fluorescence with time, indicating that two phases 
take place during the oligomerization process. A first fast 
phase of — 20 s, independent of the cholesterol content of the 
membrane, as the enhancement of acceptor fluorescence 
presents the same exponential increase for control as for
FIGURE 4. Hemolysis of HlyA employing cholesterol-depleted erythro­
cytes. A, initial hemolytic rate ( —ADO/Af) as a function of HlyA concen­
tration (/xm),employing control erythrocytes (•) and cholesterol-depleted 
erythrocytes (▼). Initial rate of hemolysis was obtained from the linear 
portion of kinetic curve (scattered light at 595 nm versus time; data not 
shown). Cholesterol was extracted from erythrocytes with egg SUV-PC 
(n = 3). B, plot of f50 versus reciprocal of toxin concentration, employing 
control erythrocytes (•) and cholesterol-depleted erythrocytes (▼). t50 
was calculated from the kinetic curve as the time required to reach half of 
the initial absorbance at 595 nm.
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cholesterol-depleted erythrocytes ghosts. On the other 
hand, the period between the two phases is cholesterol 
content-dependent because the second enhancement of 
acceptor fluorescence occurs 50 s later in cholesterol- 
depleted ghost (110 s) than in control ones (60 s).
The acceptor fluorescence of a mixture composed of unla­
beled and acceptor-labeled HlyA K344C with ghost erythro­
cytes was also measured. This mixture was excited at 480 nm, 
the excitation wavelength of the donor. As seen in Fig. 6 the 
enhancement of fluorescence is not as abrupt as in other cases. 
This demonstrates that the first phase of oligomerization 
described before corresponds to the enhancement of acceptor 
fluorescence because of FRET and not to an increase in the 
quantum yield of the fluorophore by the insertion of the toxin 
into membranes. Finally, we can hypothesize that the oligomer­
ization process occurs in two phases as follows: a first fast phase 
where small oligomers are formed, and a second phase where 
these oligomers coalesce in a large pore. This second phase is
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FIGURE 5. Oligomerization of HlyA on cholesterol-depleted ghost erythrocytes. FRET measurement of HlyA K344C using control (-CD) and cholesterol- 
depleted (+CD) sheep ghost erythrocytes is shown. In this case, the cholesterol depletion was done with 3 mM CD treatment. Lipid concentration was 0.05 mM, 
and the lipid/protein ratio was 109. FRET was calculated as mentioned before under "Experimental Procedures" (n = 4). Inset, example of spectra measured for 
HlyA K344C bound to cholesterol-depleted ghost erythrocytes. Fluorescence emission spectrum of ghost erythrocytes containing D/A, Fd/a(480, A„m) (excited 
at480nm) (•), emission spectrum of ghost erythrocytes labeled only with donor, F°(480, Aem) (gray circle), and spectrum of ghost erythrocytes containing D/A, 
Fd/a(530, A„m) (excited at 530 nm where only the acceptor absorbs) (inverted gray triangle).
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cholesterol-dependent. This means that cholesterol-enriched 
microdomains favor the fusion of oligomers.
Interaction of HlyA and Pro-HlyA with DRMs—Lt is impor­
tant to remember that the terms “membrane microdomains” 
and “DRMs” should not be used as synonyms because they have 
different origins and conceptual meanings (34). However, a 
very much used approach in the current literature to investigate 
the interaction between a protein and membrane microdo­
mains is the DRM technique. This technique takes profit from 
the selective solubilization of different lipids occurring when a 
biomembrane is submitted to the action of a nonionic deter­
gent such as Triton X-100. In this paper, this technique has 
been used to compare the affinity of HlyA and Pro-HlyA to 
DRMs. For this purpose, ghost erythrocytes were incubated 
with purified HlyA or Pro-HlyA and DRMs were separated by 
sucrose gradient ultracentrifugation as described under 
“Experimental Procedures.” DRMs fractions have been defined 
by their enrichment in cholesterol, sphingomyelin, and Flotil- 
25206 JOURNAL OF BIOLOGICAL CHEMISTRY
lin-1, a specific protein marker of erythrocyte microdomains 
(35).
Fig. 7 A shows the immunoblot analysis of these fractions, 
revealing that most of the ghost-associated HlyA has been 
detected in low density fractions (lanes 3 and 4). Control 
experiments were performed with free HlyA, i.e. in the 
absence of ghost erythrocytes. As expected, after ultracen­
trifugation, the whole toxin was found at the bottom of the 
gradient (Fig. 7B, lanes 12 and P). Hence, the ability of HlyA 
to reach the top of the gradient depends on the presence of 
cell lysate, indicating that the flotation of the toxin to the 
lighter fractions is not because of the presence of detergent 
and the centrifugation procedure. The low density fractions 
that contained HlyA were enriched in cholesterol, sphingo­
myelin (Fig. 7C), and Flotillin-1 (Fig. 7D), typical character­
istics of DRMs.
The sheep erythrocytes were then cholesterol-depleted with 
CD, and ghosts were prepared and incubated with HlyA.
VOLUME 284-NUMBER 37-SEPTEMBER 11,2009
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FIGURE 6. FRET kinetics. Measurement of acceptor fluorescence at 570 
nm asa function of time of a mixed composed by HlyA K344C labeled with 
donor and acceptor plus control erythrocytes (blackline) and cholesterol- 
depleted erythrocytes (light gray line) are shown. Measurement of a mix­
ture of unlabeled and labeled with acceptor HlyA K344C with control 
erythrocytes (dark gray line) was done as FRET negative control. Assays 
were performed at a ratio of 5 /ig of total toxin per 100 /ig of phospholip­
ids (erythrocytes membranes). The excitation monochromator was set at 
480 nm, and the emission monochromator was set at 570 nm. Alexa-546 
emission was measured ata rate of 25 samples/s during 240 s, at 37 °C. The 
curves represent the average value of three independent experiments 
obtained from five replicates each.
Finally, DRMs were obtained as described before. The immu­
noblot analysis has revealed that HlyA in low density fractions 
completely disappears (Fig. 8A, lanes 3 and 4), and it appears 
mainly at the bottom of the gradient (Fig. 8A, lanes 12 and P). 
Flo tillin-1 was exclusively located at the bottom of the gradient 
after the treatment with CD, representing a positive control for 
the disruption of DRM (Fig. 8B, lanes 12 and P).
To test if fatty acids covalently bound to protein are respon­
sible for toxin association with DRMs, Pro-HlyA has been incu­
bated with ghost erythrocytes, and DRMs have been obtained. 
Interestingly, Pro-HlyA co-localizes with HlyA and Flotillin-1 
in low density fractions of the gradient (Fig. 7E, lanes 3 and 4). 
Also, control experiments have been done with Pro-HlyA in the 
absence of ghost membrane, and it was found at the bottom of 
the gradient (data not shown) as HlyA, after Triton X-100 treat­
ment and ultracentrifugation.
To sum up, the comparison between control and cholesterol- 
depleted erythrocytes in FRET experiments, kinetic assays, and 
DRM technique confirms that cholesterol-enriched microdo­
mains facilitate the hemolytic process of HlyA. In addition, the 
fact that Pro-HlyA is found in DRMs indicates that the main 
role assigned to saturated acyl chain to target proteins to these 
microdomains is not valid for HlyA.
DISCUSSION
There is a substantial debate about how HlyA creates lesions 
in target cell membranes. Some studies have hinted that oli­
gomerization can occur, although others have suggested that 
there is neither oligomerization nor a single oligomer size. Both 
linear and nonlinear dependences of membrane conductance 
have been reported, leading to confusion about whether the 
pore formation depends on toxin oligomerization. However, in 
Oligomerization of HlyA ofE. coli
those previous studies, oligomerization has been indirectly 
examined.
Our report shows, by FRET experiments, that an oligomer 
is involved in the hemolytic mechanism of HlyA. FRET can 
be used to study the distribution of molecules in membranes 
because the average spacing between molecules of interest 
will depend primarily on their lateral distribution. Molecules 
may be within FRET distance either because they are clus­
tered or because they are randomly distributed at such high 
surface densities that there is a fraction of randomly distrib­
uted labeled molecules in FRET proximity. The last effect 
has been avoided in our experiments by using a high lipid/ 
protein molar ratio (109), to ensure that the observed FRET 
corresponds to oligomerization of the toxin on the erythro­
cyte surface (Fig. 2B).
On the other hand, the absence of FRET in the mutant 
protein, Pro-HlyA K344C (Fig. 3), confirms the participation 
of the fatty acids covalently bound in the oligomerization 
process. At first glance, this absence of FRET may be attrib­
uted to a reduced binding of the mutant protein to ghost 
erythrocytes, but this was discarded because the percentage 
of binding to membranes of both proteins is similar, as 
shown under “Results.” It is important to mention that fatty 
acids are essential for the hemolytic activity (Fig. 1) and, 
considering that the fatty acids are needed for oligomeriza­
tion, we can state that oligomerization is necessary for 
hemolysis. We feel tempted to propose that the presence of 
fatty acids covalently bound to the protein leads to the expo­
sure of regions that are implicated in protein-protein inter­
actions. In addition, an important role of acylation in the 
oligomerization process to form hemolytic pores has been 
proposed for adenylate cyclase toxin from Bordetella pertus­
sis, another RTX toxin (36).
Finally, if we consider that pores formed by HlyA are sen­
sitive to proteases on the cis side of the planar lipid mem­
branes (8), it is possible to conclude that the part of the toxin 
remaining external to the membrane is involved in protein­
protein interaction responsible for oligomerization, and 
thus in pore formation. The kinetics of HlyA-induced 
hemolysis is also consistent with multimeric pore formation. 
Simulations indicate that the escape time of a small molecule 
from a vesicle through a pore is on the order of 10 ms (37), 
which is about 50,000-fold faster than the half-time of 
hemolysis shown in Fig. 4/3. This suggests that the half-times 
represent the time required to form pores.
As seen in Fig. 4A, the hemolysis rate of cholesterol-de- 
pleted erythrocytes is lower than the hemolysis rate of con­
trol erythrocytes at each HlyA concentration tested, suggest­
ing the participation of cholesterol-enriched microdomains 
in the oligomerization process. For cholesterol-depleted 
erythrocytes, at low toxin concentration, the kinetics of 
hemolysis seems to be more complex, suggesting that toxin 
diffusion in membranes is the limiting step. This was con­
firmed with the results of FRET kinetics. The biphasic 
behavior of FRET seen in Fig. 6 suggests the first formation 
of small oligomers, followed by their assembly to form mul­
timeric structures. The concentration of the small oligomers 
is favored by the cholesterol-enriched microdomains,
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FIGURE 7. Interaction of HlyA with DRMs. A, 30 /.eg of HlyA was incubated with 100 /.cl of ghost erythro­
cytes for 30 min at 37 °C. Cells were lysed with 1% Triton X-100, and insoluble cell components were then 
separated by sucrose density gradient centrifugation. The gradient fractions were analyzed by immuno­
blotting with anti-HlyA antibodies. HlyA was present in fractions 3 and 4 (A, lanes 3 and 4).B, when sucrose 
density gradient centrifugation was applied to free HlyA, it appeared at the bottom of the gradient (B, 
lanes 12 and P). C, enrichment of cholesterol (Ch) and sphingomyelin (SM) in DRM was performed by high 
performance TLC analysis. Total lipids of sucrose density gradient fractions were extracted by the proce­
dure of Folch. Lipids were recovered from the original chloroform extract and subjected to analysis on 
high performance TLC plates, developed with a two solvent system. Because Triton X-100 in the bottom 
fractions (lanes 7-12) interferes with the separation of lipids on TLC plates, the distribution pattern of 
cholesterol and sphingomyelin in these fractions was not shown. D, gradient fractions were also analyzed 
by immunoblotting with ant i-Fl oti 11 i n-1 antibodies. Flotillin-1 appears mainly in fractions 3 and 4 (D, lanes 
3 and 4). E, Pro-HlyA was incubated in the same conditions as HlyA. The gradient fractions were analyzed 
by immunoblotting with anti-HlyA antibodies. Pro-HlyA co-localizes with HlyA (E, lanes 3 and 4).
diminishing the diffusion time in the membrane. The num­
ber of HlyA molecules that associate to form the pore is 
uncertain; however, it is not unreasonable to assume that 
several molecules could oligomerize to form a pore. An 
extension of this reasoning suggests that at high doses pro­
gressive oligomerization of HlyA leads to the fusion of the 
pore and rapid destruction of the cell membrane with little 
time for activation of the central apoptotic pathway. On the 
other hand, at lower concentra­
tion, pores would be smaller and 
fewer in number so that cells, 
although injured, survive long 
enough so that apoptosis can be 
observed (38).
These results can explain why 
toxin association with erythro­
cytes at 0-2 °C is characterized as 
a prelytic state, and following a 
shift to 23 °C, after a lag period, 
lysis begins (16). In conclusion, the 
fusion of oligomers may be the 
rate-limiting step in pore forma­
tion, and the integrity of the cho- 
lesterol-enriched microdomains is 
necessary for the local concentra­
tion of HlyA-induced hemolysis. 
This is in agreement with Moayeri 
and Welch (13), who observed that 
the degree of osmotic protection 
of erythrocytes afforded by pro­
tectants of varying sizes depends 
on the amount of toxin applied 
and the duration of the assay. They 
suggest that HlyA creates a lesion 
with a very small initial size that 
increases in apparent diameter 
over time. Consequently, the 
larger the oligomer, the bigger the 
pore size becomes.
In this study, we provide direct 
biochemical evidence indicating 
that HlyA associates with DRMs. 
When ghost erythrocytes were 
incubated with purified HlyA and 
DRMs were separated by sucrose 
gradient ultracentrifugation, the 
immunoblot analysis revealed that 
most of the ghost-associated HlyA 
was associated with DRMs (Fig. 
7A, lanes 3 and 4). The data sug­
gest that the binding of HlyA to 
erythrocyte membranes is medi­
ated by membrane microdomains 
that serve as concentration plat­
forms for the toxin oligomeriza­
tion as we have demonstrated 
previously (Fig. 6). The fact that 
Pro-HlyA co-localizes with HlyA 
and flotillin in DRMs (Fig. 7E, lanes 3 and 4) emphasizes our 
hypothesis that the main role of the saturated acyl chain 
covalently bound to HlyA is the participation in the oli­
gomerization process, and not the targeting to cholesterol- 
enriched membranes.
A key feature of cholesterol-enriched microdomains is the 
tight packing of lipid acyl chains in the liquid-ordered phase, 
in which lipid acyl chains are extended and ordered (14).
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FIGURE 8. Interaction of HlyA with cholesterol-depleted erythrocytes. Thirty micrograms of HlyA was 
incubated with 100 /xl of cholesterol-depleted ghost erythrocytes for 30 min at 37 °C. Cells were lysed with 
1% Triton X-100, and insoluble cell components were then separated by sucrose density gradient centrif­
ugation. The gradient fractions were analyzed by immunoblotting with anti-HlyA (A) and anti-Flotillin-1 
(B) antibodies.
Because of the difficulty in packing membrane-spanning hel­
ices into the ordered lipid environment, some proteins are 
linked to saturated acyl chains, which partition well into 
them (39). However, Shogomori et al. (40) have found that 
acylation does not measurably enhance microdomain asso­
ciation, and they have concluded that the acylated linker for 
activation of T cell transmembrane domain has low inherent 
cholesterol-enriched microdomain affinity. It is possible to 
conclude that acylation is not sufficient for the targeting of 
any transmembrane protein, and a second mechanism, such 
as protein-protein interactions for microdomains associa­
tion, is required (41, 42).
In this context, our results show that there is no difference in 
DRMs association between acylated and unacylated HlyA. 
However, FRET experiments clearly show the importance of 
the acyl chain covalently bound to toxin in the oligomerization 
is essential for the lytic process (Fig. 3).
Recent results we have published are consistent with a 
molten globular form of the acylated protein. Moreover, we 
have proposed that the fatty acids covalently bound to the 
protein expose intrinsically disordered regions present in 
the toxin sequence that may be involved in different steps of 
the action mechanism of the toxin (6). The intrinsic lack of 
structure can confer functional advantages on the protein, 
including the ability to bind to several different targets or, 
among toxin monomers, to form the active oligomer respon­
sible for the hemolytic action of the toxin. In addition, we 
have found that the presence of two acyl chains in HlyA 
confers this protein with the property of irreversible binding 
to membranes, which is essential for the lytic process to take 
place (7).
The formation of oligomers by HlyA is consistent with the 
results of lipid bilayer experiments with asolectin mem­
branes. In those experiments, we have found that HlyA 
increases membrane conductance by many orders of magni­
tude in a concentration-dependent fashion. An amplitude 
histogram of HlyA pores demonstrates a significant depend­
ence of pore size on toxin concentration, indicating a possi­
ble participation of a variable number of monomers in the 
structure of a pore.5
5 V. Herlax and L. Bakâs, unpublished results.
In this way, HlyA pore behavior differs from the fixed oligo­
meric stoichiometric seen in other membrane-inserting toxins 
such as staphylococcal a-hemolysin (43). Rather, HlyA oli­
gomerization appears to be more similar to that of the diphthe­
ria toxin, which can form pores and 
oligomers of various size (44).
To conclude, we propose that 
fatty acids covalently bound to 
HlyA and membrane microdo­
mains are implicated in the hemol­
ysis process. Fatty acids are essen­
tial because they expose intrinsic 
disorder regions that enhance pro­
tein-protein interaction to form 
the oligomer, and the membrane 
microdomains act as platforms 
that concentrate the toxin in this oligomerization process. 
Unfortunately, pore size cannot be used to estimate the 
monomer number, because the HlyA pore is partly bordered 
by lipids (12).
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